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Abstract
The food enzyme considered in this opinion is a b-amylase (4-a-D-glucan maltohydrolase; EC 3.2.1.2),
produced with genetically modiﬁed Bacillus licheniformis strain NZYM-JA by Novozymes A/S (Denmark).
The b-amylase food enzyme is intended to be used in starch processing for the production of glucose
syrups. Since the residual amounts of total organic solids (TOS) in glucose syrups after ﬁltration and
puriﬁcation during starch processing were considered negligible, no dietary exposure was calculated.
Toxicological tests made with the food enzyme under application indicated that there was no concern
with respect to genotoxicity, mutagenicity or systemic toxicity. The allergenicity was evaluated by
searching for similarity of the amino acid sequence to those of known allergens; no match was found.
The Panel considers that there are no indications for allergic reactions. Based on the genetic
modiﬁcations performed, the manufacturing process, the compositional and biochemical data provided,
the ﬁndings in the toxicological studies and allergenicity assessment, the Panel concludes that this food
enzyme does not give rise to safety concerns under the intended conditions of use.
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1. Introduction
Article 3 of the Regulation (EC) No 1332/20081 provides deﬁnition for ‘food enzyme’ and ‘food
enzyme preparation’.
‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products
thereof obtained by a fermentation process using microorganisms: (i) containing one or more enzymes
capable of catalysing a speciﬁc biochemical reaction and (ii) added to food for a technological purpose
at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage
of foods.
‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which
substances such as food additives and/or other food ingredients are incorporated to facilitate their
storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were regulated as processing aids under the legislation of the Member States. On 20 January 2009,
Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes
that are added to food to perform a technological function in the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No 1331/20082 established European Union (EU) procedures for the
safety assessment and the authorisation procedure of food additives, food enzymes and food
ﬂavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
• it does not pose a safety concern to the health of the consumer at the level of use proposed,
• there is a reasonable technological need, and
• its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market, as well as all
new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on a food enzyme for evaluation’ (EFSA, 2009a) lays
down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the EU Community list may be placed on the market as such and
used in foods, in accordance with the speciﬁcations and conditions of use provided for in Article 7 (2)
of Regulation (EC) No 1332/2008 on food enzymes. According to this Regulation, a food enzyme that
falls within the scope of Regulation (EC) No 1829/20033 on genetically modiﬁed food and feed should
be authorised in accordance with that Regulation as well as under this Regulation.
An application has been introduced by Novozymes A/S for authorisation of the food enzyme
b-amylase obtained by fermentation with the genetically modiﬁed Bacillus licheniformis NZYM-JA.
Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/20114
implementing Regulation (EC) No 1331/20082, the Commission has veriﬁed that the application falls
within the scope of the food enzyme Regulation and contains all the elements required under Chapter
II of that Regulation.
1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive
2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7–15.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food ﬂavourings. OJ L 354, 31.12.2008, p. 1–6.
3 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
4 Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
ﬂavourings. OJ L 64, 11.3.2011, p. 15–24.
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1.1.2. Terms of Reference
The European Commission requests EFSA to carry out the safety assessment on the food enzyme
b-amylase obtained with the genetically modiﬁed strain of Bacillus licheniformis NZYM-JA in accordance
with Article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.
1.2. Information on existing authorisation and evaluations
The applicant indicated that this food enzyme has not been evaluated by authorities in the EU.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of the application for authorisation of the food
enzyme b-amylase produced with a genetically modiﬁed B. licheniformis (strain NZYM-JA). The food
enzyme is intended to be used in starch processing for the production of glucose syrups.5
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA, 2009b) and following the relevant
Guidances from the EFSA Scientiﬁc Committee.
The current guidance on the submission of a dossier for safety evaluation of a food enzyme (EFSA,
2009a) has been followed by the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids (CEF) for the evaluation of the application with the exception of the exposure
assessment, which was carried out in accordance to the methodology described in the CEF
Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: b-amylase
Systematic name: 4-a-D-Glucan maltohydrolase
Synonyms: Saccharogen amylase, glycogenase, 1,4-a-D-glucan maltohydrolase
IUBMB No: EC 3.2.1.2
CAS No: 9000-91-3
EINECS No: 232-566-1.
3.1.2. Chemical parameters
The b-amylase produced with the genetically modiﬁed strain B. licheniformis NZYM-JA consists of a
single polypeptide of 515 amino acids. The 57.6 kDa molecular mass of the protein was calculated based
on the amino acid sequence. The protein homogeneity of the food enzyme was investigated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis for three commercial batches.
The apparent molecular mass based on the SDS-PAGE pattern is about 58 kDa (equivalent to the
calculated molecular mass). The gel presented showed the same pattern in all samples, consisting of one
main protein band and a number of much weaker bands.
The food enzyme was tested for other enzyme activities in the food enzyme product, i.e. a-
amylase, glucoamylase, lipase and protease, which were below the limits of detection. No other
enzymatic side activities have been reported by the applicant.
Data on the chemical parameters of the food enzyme have been provided for three commercial
food enzyme batches and one batch to be used for toxicological tests (Table 1). The average total
organic solids (TOS) of the three commercial food enzyme batches was 10.9% (w/w); the values
ranged from 10.5% to 11.3%.
5 European Commission working document describing the food processes in which food enzymes are intended to be used – not
yet published at the time of adoption of this opinion.
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The average enzyme activity/TOS ratio of the three food enzyme batches for commercialisation was 101.3
b-amylase Units/mg TOS (BAMU/mg TOS); the values ranged from 95.4 to 105.7 BAMU/mg TOS (Table 1).
The applicant provided analytical data on the three commercial batches and the batch used for
toxicological studies, demonstrating that the content of lead (< 0.5 mg/kg) was below the speciﬁcation
for lead (≤ 5 mg/kg) as laid down in the general speciﬁcations and considerations for enzymes used in
food processing (FAO/WHO, 2006). Furthermore, the levels of arsenic, cadmium and mercury were
below their respective levels of detection (As: 0.3 mg/kg; Cd and Hg: 0.05 mg/kg). No antimicrobial
activity was detected in any of these batches (FAO/WHO, 2006).
The food enzyme complies with the microbiological criteria as laid down in the general
speciﬁcations and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
should not exceed 30 colony forming units (CFU) per gram.
The applicant has provided information on the identities of the antifoam agents used and method
for analysis. Taking into account the nature and properties of the antifoam agents, the manufacturing
process and the quality assurance system implemented by the applicant, the Panel considers their use
as of no safety concern.
The Panel considered the compositional data provided for the food enzyme as sufﬁcient.
3.1.3. Properties of the food enzyme
The b-amylase catalyses the hydrolysis of 1,4-a-glycosidic linkages in starch and successively
releases maltose units from the non-reducing ends of the chains.
The b-amylase activity is quantiﬁed based on the hydrolysis of the maltohexaose substrate to form
maltose and maltotetraose and is expressed in BAMU/g. The analytical principle is based on the
reaction between maltotetraose and lactose-oxidase and O2, which produces hydrogen peroxide. This,
in turn, in the presence of peroxidase, activates the oxidative condensation of 4-aminoantipyrine (AA)
and N-ethyl-N-sulfopropyl-m-toluidine (reaction conditions: 37°C, pH 5.5; reaction time: 260 s) to form
a purple product which is determined spectrophotometrically at 540 nm. Activity is calculated based on
a standard with a known enzymatic activity.
The temperature proﬁle of the b-amylase was measured between 30°C and 95°C at pH 5.0. The
optimum temperature for activity was 60°C with virtually all activity lost by 80°C. The pH proﬁle
measured between pH 2.0 and 10.0 at 60°C showed optimum activity between pH 5.0 and 8.0. The
thermostability of the b-amylase was tested at temperatures from 20°C to 95°C after an incubation
period of 30 min at pH 5.0. The b-amylase stability decreases rapidly after 60°C showing no residual
activity at 70°C. The activity itself was measured under standard assay conditions.
3.1.4. Information on the source material
3.1.4.1. Information related to the genetically modiﬁed microorganism
The b-amylase production strain B. licheniformis NZYM-JA is deposited in the DSMZ with the
deposit number
Table 1: Compositional data of the food enzyme
Parameter Units
Batches
1 2 3 4(a)
b-Amylase activity BAMU/g batch(b) 11,100 10,300 11,600 9,544
Protein % 9.3 8.7 9.5 NA(c)
Ash % 0.4 0.5 0.4 1.2
Water % 89.1 88.7 88.3 87.3
Total organic solids (TOS)(d) % 10.5 10.8 11.3 11.5
b-Amylase activity/mg TOS BAMU/mg TOS 105.7 95.4 102.7 83.0
(a): Batch used for the toxicological testings.
(b): BAMU/g batch: b-amylase Units (see Section 3.1.3).
(c): NA: Not Analysed.
(d): TOS calculated as 100% – % water – % ash.
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3.1.4.2. Characteristics of the recipient or parental microorganisms
The parental strain was identiﬁed as B. licheniformis by 16S rRNA sequence analysis.
B. licheniformis has been recommended for Qualiﬁed Presumption of Safety (QPS) status, with the
qualiﬁcation that the absence of acquired antibiotic resistance genes and toxigenic activity are veriﬁed for
the speciﬁc strain used (EFSA BIOHAZ Panel, 2017a,b). The identity of the parental strain has been
conﬁrmed and has been shown to have no cytotoxic activity in Chinese hamster ovary cells (Pedersen
et al., 2002) and VERO cells. Additionally it was demonstrated that the strain did not react with antibodies
against Bacillus cereus enterotoxins by using commercial antibody-based kits.
Consequently, the parental strain is presumed to be safe for production purposes.
The recipient strain, B. licheniformis , has been developed from the parental strain
Safety of the food enzyme b-amylase from Bacillus licheniformis NZYM-JA
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3.1.4.3. Characteristics of the donor organisms
3.1.4.4. Description of the genetic modiﬁcation process
The production strain B. licheniformis NZYM-JA was developed from the recipient strain
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3.1.4.5. Safety aspects of the genetic modiﬁcations
3.1.5. Manufacturing process
The food enzyme is manufactured with food safety procedures based on Hazard Analysis and
Critical Control Points (HACCP), in accordance with current Good Manufacturing Practice (GMP) and,
when produced in the EU, in accordance with the Food Hygiene Regulation (EC) No 852/20046.
The food enzyme is produced by a pure culture in a contained, submerged, fed-batch fermentation
system with conventional process controls in place. The identity and purity of the culture are checked
at each transfer step from frozen vials until the end of fermentation.
The downstream processing includes recovery, puriﬁcation, concentration and stabilisation. The
food enzyme produced is recovered from the fermentation broth after biomass separation via press
ﬁltration. The liquor is then ﬁltered to remove the remaining microorganisms, and concentrated by
ultraﬁltration, which removes the low-molecular-weight material.
Subsequently, the food enzyme concentrate is formulated and commercialised as a liquid or a solid
preparation. To this end, the concentrated food enzyme solution is stabilised by the addition of
preservatives , and ﬁnally subjected to polish- and
germ-ﬁltration.
The absence of the production strain in the product was demonstrated in
No recombinant DNA was detected in three independent batches in triplicate
The Panel considered the information provided on the raw materials and the manufacturing process
as sufﬁcient.
3.1.6. Safety for the environment
Neither the production strain nor its recombinant DNA was detected in the ﬁnal product.
Accordingly, no environmental risk assessment is required (EFSA GMO Panel, 2011).
3.1.7. Reaction and fate in food
The b-amylase catalyses the hydrolysis of 1,4-a-glycosidic linkages of starch (amylose and
amylopectin), and successively releases maltose units from the non-reducing ends of the chains,
resulting in the production of limit dextrins and maltose.
6 Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives.
OJ L 226, 25.6.2004, p. 3–21.
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The b-amylase is speciﬁc in its action and is not known to catalyse reactions other than the
hydrolysis of starch. These reaction products, i.e. maltose and the remaining oligosaccharides are
naturally present in starch-containing foods.
The information and data provided indicate that the b-amylase is removed during processing under
the intended conditions of use (starch processing: ﬁltration, carbon treatment and ion exchange).
The food enzyme was tested for the presence of other enzyme activities, i.e. a-amylase,
glucoamylase, lipase and protease, which were below the limits of detection. No other side activities
have been reported by the applicant.
3.1.8. Case of need and intended conditions of use
As proposed by the applicant, the food enzyme is intended for use in starch processing for the
production of glucose syrups containing maltose (glucose syrup with high maltose content, glucose
syrup containing maltose and dried glucose syrup containing maltose), at an intended use level of up
to 98.7 mg TOS/kg starch.
In starch processing, the b-amylase is added after the liquefaction during the sacchariﬁcation step
in order to convert liqueﬁed starch into maltose-rich glucose syrups.
According to the applicant, the food enzyme is used at the minimum amount necessary to achieve
the desired reaction according to GMP. The use level applied by a food manufacture in practice
depends on the particular process.
3.2. Dietary exposure
For this application, the intended use of this b-amylase is to hydrolyse starch in order to produce
maltose-containing glucose syrups. Experimental data on the signiﬁcant removal (> 99%) of protein in
the course of this process have been provided (Documentation provided to EFSA n. 4). The
Panel considered this evidence as sufﬁcient to conclude that the presence of residual amounts of TOS
after the puriﬁcation steps applied during the production of glucose syrups, i.e. ﬁltration, ion exchange
chromatography, carbon treatment and crystallisation, is negligible. Consequently, no exposure was
calculated.
3.3. Toxicological data
The following toxicity data have been provided by the applicant: a bacterial reverse mutation test,
an in vitro micronucleus assay and a repeated dose 90-day oral toxicity study in rodents. All the
toxicological studies were performed with batch 4 (Table 1), having higher ash content and a lower
enzyme activity per g food enzyme and per mg TOS in comparison to the reference batches.
3.3.1. Bacterial reverse mutation test
A bacterial reverse mutation assay (Ames test) was performed according to the OECD Test
Guideline 471 (OECD, 1997) and following Good Laboratory Practice (GLP) in four strains of Salmonella
Typhimurium (TA1535, TA1537, TA98 and TA100) and E. coli WP2uvrA pKM 101, in the presence or
absence of metabolic activation (S9-mix) applying a ‘treat and plate’ assay using six different
concentrations (0, 156, 313, 625, 1,250, 2,500 and 5,000 lg TOS/mL) of the food enzyme using
appropriate positive controls and water as a negative control. Upon treatment with the food enzyme,
there was no increase in revertant colony numbers. Therefore, the Panel concluded that the food
enzyme did not induce gene mutations under the conditions employed in this study.
3.3.2. In vitro micronucleus assay
The in vitro micronucleus assay was carried out according to the OECD Test Guideline 487 (OECD,
2010) and following GLP. Human peripheral whole blood cultures were exposed to the food enzyme for
a short treatment (3 h + 18 h recovery) in the presence and absence of S9 mix and a continuous
treatment (24 h + 24 h recovery) without S9 mix using a concentration range from 500 to 5,000 lg
TOS/mL. No biological relevant increase in the frequency of micronuclei (MN) was observed after
treatment with the test article at the concentrations analysed. The Panel concluded that the food
enzyme b-amylase did not induce MN under the test conditions employed.
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3.3.3. Repeated dose 90-day oral toxicity study in rodents
A repeated dose 90-day oral toxicity study was performed according to the OECD test guideline 408
(OECD, 1998) and following GLP. Groups of 10 male and ten female Sprague–Dawley (Crl:CD(SD)) rats
received daily via gavage for 90 days dose levels of 0 (reverse osmosis water as vehicle), 10%, 33%
and 100% of the food enzyme in a ﬁnal dose volume of 10 mL/kg body weight (bw)corresponding to
0, 120, 396 and 1,199 mg TOS/kg bw per day.
No treatment-related death or effects on clinical signs, general appearance and behaviour, sensory
reactivity responses, grip strength and motor activity were observed. A statistically signiﬁcant increase
of overall weight gain and feed intake was observed in males but was no dose related and therefore
considered of no toxicological importance.
All other intergroup differences of haematology and clinical chemistry parameters from controls
were minor, conﬁned to one sex or lacked dose-relationship and can be attributed to normal biological
variation.
Variation in neurobehaviour parameters showed no consistent association with consumption of the
food enzyme by either sex.
The Panel concluded that the no-observed-adverse-effect-level (NOAEL) was the highest
concentration tested, which corresponds to 1,199 mg TOS/kg bw per day.
3.4. Allergenicity
The potential allergenicity of b-amylase produced with the genetically modiﬁed B. licheniformis
strain NZYM-JA was assessed by comparing its amino acid sequence with those of known allergens
according to the scientiﬁc opinion on the assessment of allergenicity of genetically modiﬁed (GM)
plants and microorganisms and derived food and feed of the Scientiﬁc Panel on Genetically Modiﬁed
Organisms (EFSA GMO Panel, 2010). Using higher than 35% identity in a window of 80 amino acids as
the criterion, no match was found.
b-Amylase from B. licheniformis is not described as a potential allergen and no food allergic
reactions to this food enzyme have been reported, so there is no evidence for potential allergenicity of
this food enzyme.
According to the information provided, substances or products that may cause allergies or
intolerances (Regulation EU 1169/2011)7 are used as raw materials ) in the media fed to
the microorganisms in the course of the production of the enzyme. However, the proteins will be
digested during the fermentation process and consumed by the microorganisms for cell growth, cell
maintenance and production of enzyme protein. In addition, the microbial biomass and fermentation
solids will be removed. Therefore, potentially allergenic residues of these foods employed as protein
sources are not expected to be present.
Taken together, the Panel considers that there are no indications for allergic reactions, and
therefore, this b-amylase produced with the genetically modiﬁed B. licheniformis (strain NZYM-JA) is
not of safety concern.
Conclusions
Based on the genetic modiﬁcations performed, the manufacturing process, the compositional and
biochemical data provided, the ﬁndings in the toxicological studies and allergenicity assessment, the
Panel concludes that this food enzyme does not give rise to safety concerns under the intended
conditions of use.
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(Søborg, Denmark) on 17 November 2016, respectively.
3) Additional information was received from Novozymes A/S on February 2017.
4) Additional information on “Food enzyme removal during the production of cereal based
distilled alcoholic beverages” and “Food enzyme carry/over in glucose syrups”. February
2017. Provided by the Association of Manufacturers and Formulators of Enzyme Products.
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Abbreviations
AA 4-aminoantipyrine
BAMU b-amylase Units
bw body weight
CAS Chemical Abstracts Service
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CEF EFSA Panel on Food Contact Material, Enzymes, Flavourings and Processing Aids
CFU colony forming unit
DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany
EC Enzyme Commission
EINECS European Inventory of Existing Commercial Chemical Substances
FAO Food and Agricultural Organization
GLP Good Laboratory Practice
GM genetically modiﬁed
GMO genetically modiﬁed organism
GMP Good Manufacturing Practice
HACCP Hazard Analysis and Critical Control Points
IUBMB International Union of Biochemistry and Molecular Biology
JECFA Joint FAO/WHO Expert Committee on Food Additives
MN micronuclei
NOAEL no-observed-adverse-effect-level
OECD Organisation for Economic Cooperation and Development
PCR polymerase chain reaction
QPS Qualiﬁed Presumption of Safety
rRNA ribosomal ribonucleic acid
SDS-PAGE sodium dodecyl sulfate-poly acrylamide gel electrophoresis
TOS total organic solids
WHO World Health Organization
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